Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks to host Q3 2026 results presentation on November 5, 2026

Neutral Impact 2 of 5 earnings Written later

Ginkgo Bioworks announced it will hold a presentation and Q&A session on November 5, 2026, to review business performance for the third quarter ended September 30, 2026. The filing announces the timing only and does not disclose any quarterly financial results.

Key points

  • Presentation and Q&A session set for Thursday, November 5, 2026, beginning at 4:30 p.m. ET
  • Webcast details and a replay will be posted on Ginkgo's investor relations website
  • Shareholders can submit questions via X (hashtag #GinkgoResults) or by email to investors@ginkgobioworks.com

The filing

CompanyGinkgo Bioworks Holdings, Inc. (DNA)
Form8-K, current report
Filed with the SECOct 29, 2026, 4:06 PM ET
Accession number0001628280-26-068220

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.